594 related articles for article (PubMed ID: 11279981)
1. [New drugs for diabetes treatment. Fast-acting insulin analogues].
Forst T
Pharm Unserer Zeit; 2001; 30(2):118-23. PubMed ID: 11279981
[No Abstract] [Full Text] [Related]
2. An update on the long-acting insulin analogue glargine.
Thisted H; Johnsen SP; Rungby J
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
[TBL] [Abstract][Full Text] [Related]
3. [What is new in the treatment of diabetes mellitus?].
Gain T
Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
[No Abstract] [Full Text] [Related]
4. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
5. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin.
Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288
[No Abstract] [Full Text] [Related]
6. Insuline glusine (Apidra): a new rapid-acting insulin.
Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
[TBL] [Abstract][Full Text] [Related]
7. Insulin glulisine. Aventis Pharma.
Barlocco D
Curr Opin Investig Drugs; 2003 Oct; 4(10):1240-4. PubMed ID: 14649217
[TBL] [Abstract][Full Text] [Related]
8. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
9. [Insulin therapy].
Brunetti P
Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
[TBL] [Abstract][Full Text] [Related]
10. Insulin analogues.
Hirsch IB
N Engl J Med; 2005 Jan; 352(2):174-83. PubMed ID: 15647580
[No Abstract] [Full Text] [Related]
11. Short-acting insulin analogues vs. human insulin for diabetes.
Schooff M; Ehlers K
Am Fam Physician; 2005 Sep; 72(5):805-7. PubMed ID: 16156336
[No Abstract] [Full Text] [Related]
12. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
13. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
Crasto W; Jarvis J; Khunti K; Davies MJ
Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878
[TBL] [Abstract][Full Text] [Related]
14. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
15. [Fast-acting insulin analogs in the treatment of juvenile diabetes].
Tuominen JA; Karonen SL; Melamies L; Koivisto V
Duodecim; 1995; 111(3):232-6. PubMed ID: 8654285
[No Abstract] [Full Text] [Related]
16. New strategies in insulin treatment: analogues and noninvasive routes of administration.
Rungby J; Brock B; Schmitz O
Fundam Clin Pharmacol; 2005 Apr; 19(2):127-32. PubMed ID: 15810892
[TBL] [Abstract][Full Text] [Related]
17. Insulin detemir. Novo Nordisk.
Barlocco D
Curr Opin Investig Drugs; 2003 Apr; 4(4):449-54. PubMed ID: 12808886
[TBL] [Abstract][Full Text] [Related]
18. More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.
Moodie P
N Z Med J; 2006 Jun; 119(1236):U2040. PubMed ID: 16807582
[No Abstract] [Full Text] [Related]
19. The evidence for insulin lispro.
McCormack J; Bassett K
CMAJ; 1998 Dec; 159(11):1353-5. PubMed ID: 9861200
[No Abstract] [Full Text] [Related]
20. [Long-acting insulin analogs: progressing slowly].
Holleman F; Hoekstra JB
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
